Anda di halaman 1dari 9

Frequency Table

Usia

Frequency Percent Valid Percent Cumulative


Percent

50-59 tahun 11 36.7 36.7 36.7

60-69 tahun 14 46.7 46.7 83.3

Valid 70-79 tahun 4 13.3 13.3 96.7

> 79 tahun 1 3.3 3.3 100.0

Total 30 100.0 100.0

Ka t.Li ngkar P inggang

Cumulative
Frequency Percent Valid P erc ent Percent
Valid Berisik o 18 60.0 60.0 60.0
Tidak B eris iko 12 40.0 40.0 100.0
Total 30 100.0 100.0

Te kanan Dara h

Cumulative
Frequency Percent Valid Perc ent Percent
Valid Berisik o 19 63.3 63.3 63.3
Tidak Beris iko 11 36.7 36.7 100.0
Total 30 100.0 100.0

Ka t. Trigli seri da

Cumulative
Frequency Percent Valid P erc ent Percent
Valid Berisik o 20 66.7 66.7 66.7
Tidak B eris iko 10 33.3 33.3 100.0
Total 30 100.0 100.0

Ka t. HDL

Cumulative
Frequency Percent Valid P erc ent Percent
Valid Berisik o 20 66.7 66.7 66.7
Tidak B eris iko 10 33.3 33.3 100.0
Total 30 100.0 100.0
Ka t.Ka dar Gula Puasa

Cumulative
Frequency Percent Valid Perc ent Percent
Valid Berisik o 27 90.0 90.0 90.0
Tidak Beris iko 3 10.0 10.0 100.0
Total 30 100.0 100.0

Si ndrom M eta bol ik

Cumulative
Frequency Percent Valid P erc ent Percent
Valid Ya 17 56.7 56.7 56.7
Tidak 13 43.3 43.3 100.0
Total 30 100.0 100.0

BP H

Cumulative
Frequency Percent Valid P erc ent Percent
Valid Ya 13 43.3 43.3 43.3
Tidak 17 56.7 56.7 100.0
Total 30 100.0 100.0

Diagnosis non BPH

Cumulative
Frequency Percent Valid Percent Percent
Valid Batu ureter 2 6.7 6.7 6.7
BPH 13 43.3 43.3 50.0
Ca buli 3 10.0 10.0 60.0
Ca prostat 1 3.3 3.3 63.3
Kis ta ginjal 1 3.3 3.3 66.7
Nefrolitiasis 8 26.7 26.7 93.3
Striktur uretra 1 3.3 3.3 96.7
Varikokel 1 3.3 3.3 100.0
Total 30 100.0 100.0
Means

Report

Std.
Sindrom Metabolik Minimum Maximum Median Mean Deviation
Ya Lingkar Pinggang 90.00 107.00 98.50 98.88 5.18
Us ia 50.00 77.00 61.00 61.24 8.24
Sis tole 70.00 160.00 130.00 124.35 20.86
Diastole 58.00 124.00 80.00 84.35 18.91
Trigliserida 89.00 535.00 183.00 236.18 137.94
HDL 6.00 60.00 39.00 38.12 13.55
Kadar Gula Puasa 96.00 296.00 132.00 159.12 59.73
Tidak Lingkar Pinggang 69.00 102.00 80.00 81.31 9.02
Us ia 50.00 84.00 62.00 64.46 9.86
Sis tole 90.00 160.00 120.00 124.92 23.39
Diastole 60.00 90.00 70.00 73.54 9.97
Trigliserida 57.00 229.00 132.00 140.46 62.42
HDL 18.00 72.00 39.00 40.31 14.66
Kadar Gula Puasa 91.00 172.00 112.00 121.23 25.51
Total Lingkar Pinggang 69.00 107.00 93.75 91.27 11.27
Us ia 50.00 84.00 61.50 62.63 8.96
Sis tole 70.00 160.00 130.00 124.60 21.60
Diastole 58.00 124.00 80.00 79.67 16.38
Trigliserida 57.00 535.00 153.00 194.70 120.16
HDL 6.00 72.00 39.00 39.07 13.84
Kadar Gula Puasa 91.00 296.00 126.00 142.70 51.01
Crosstabs

Kat.Lingkar Pinggang * BPH

Crosstab

BPH
Ya Tidak Total
Kat.Lingkar Berisik o Count 9 9 18
Pinggang Ex pec ted Count 7.8 10.2 18.0
% within Kat.
50.0% 50.0% 100.0%
Lingkar Pinggang
% within BPH 69.2% 52.9% 60.0%
Tidak Beris iko Count 4 8 12
Ex pec ted Count 5.2 6.8 12.0
% within Kat.
33.3% 66.7% 100.0%
Lingkar Pinggang
% within BPH 30.8% 47.1% 40.0%
Total Count 13 17 30
Ex pec ted Count 13.0 17.0 30.0
% within Kat.
43.3% 56.7% 100.0%
Lingkar Pinggang
% within BPH 100.0% 100.0% 100.0%

Chi-Square Te sts

As ymp. Sig. Ex act Sig. Ex act Sig.


Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .814b 1 .367
Continuity Correctiona .277 1 .599
Lik elihood Ratio .824 1 .364
Fis her's Ex act Test .465 .301
Linear-by-Linear
.787 1 .375
As soc iation
N of Valid Cases 30
a. Computed only for a 2x 2 table
b. 0 c ells (.0% ) have expected count less t han 5. The minimum expected count is 5.
20.

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for Kat.Lingkar Pinggang (Berisiko / Tidak Berisiko) 2.000 .440 9.096
For cohort BPH = Ya 1.500 .595 3.779
For cohort BPH = Tidak .750 .407 1.382
N of Valid Cases 30
Tekanan Darah * BPH

Crosstab

BPH
Ya Tidak Total
Tekanan Berisiko Count 11 8 19
Darah Expected Count 8.2 10.8 19.0
% within Tekanan Darah 57.9% 42.1% 100.0%
% within BPH 84.6% 47.1% 63.3%
Tidak Beris iko Count 2 9 11
Expected Count 4.8 6.2 11.0
% within Tekanan Darah 18.2% 81.8% 100.0%
% within BPH 15.4% 52.9% 36.7%
Total Count 13 17 30
Expected Count 13.0 17.0 30.0
% within Tekanan Darah 43.3% 56.7% 100.0%
% within BPH 100.0% 100.0% 100.0%

Chi-Square Te sts

As ymp. Sig. Ex act Sig. Ex act Sig.


Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 4.474b 1 .034
Continuity Correctiona 3.003 1 .083
Lik elihood Ratio 4.759 1 .029
Fis her's Ex act Test .057 .040
Linear-by-Linear
4.325 1 .038
As soc iation
N of Valid Cases 30
a. Computed only for a 2x 2 table
b. 1 c ells (25. 0%) have ex pect ed c ount less than 5. The minimum ex pec ted c ount is 4.
77.

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for Tekanan
Darah (Berisiko / Tidak 6.188 1.041 36.779
Berisiko)
For cohort BPH = Ya 3.184 .858 11.812
For cohort BPH = Tidak .515 .283 .934
N of Valid Cases 30
Kat. Trigliserida * BPH

Crosstab

BPH
Ya Tidak Total
Kat. Triglis erida Berisiko Count 9 11 20
Expected Count 8.7 11.3 20.0
% within Kat. Triglis erida 45.0% 55.0% 100.0%
% within BPH 69.2% 64.7% 66.7%
Tidak Beris iko Count 4 6 10
Expected Count 4.3 5.7 10.0
% within Kat. Triglis erida 40.0% 60.0% 100.0%
% within BPH 30.8% 35.3% 33.3%
Total Count 13 17 30
Expected Count 13.0 17.0 30.0
% within Kat. Triglis erida 43.3% 56.7% 100.0%
% within BPH 100.0% 100.0% 100.0%

Chi-Square Te sts

As ymp. Sig. Ex act Sig. Ex act Sig.


Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .068b 1 .794
Continuity Correctiona .000 1 1.000
Lik elihood Ratio .068 1 .794
Fis her's Ex act Test 1.000 .554
Linear-by-Linear
.066 1 .798
As soc iation
N of Valid Cases 30
a. Computed only for a 2x 2 table
b. 1 c ells (25. 0%) have ex pect ed c ount less than 5. The minimum ex pec ted c ount is 4.
33.

Ri sk Estimate

95% Confidence
Int erval
Value Lower Upper
Odds Ratio for Kat. Triglis erida
1.227 .263 5.734
(Berisiko / Tidak Beris iko)
For cohort BPH = Ya 1.125 .457 2.769
For cohort BPH = Tidak .917 .482 1.743
N of Valid Cas es 30
Kat. HDL * BPH

Crosstab

BPH
Ya Tidak Total
Kat. HDL Berisiko Count 10 10 20
Expected Count 8.7 11.3 20.0
% within Kat. HDL 50.0% 50.0% 100.0%
% within BPH 76.9% 58.8% 66.7%
Tidak Beris iko Count 3 7 10
Expected Count 4.3 5.7 10.0
% within Kat. HDL 30.0% 70.0% 100.0%
% within BPH 23.1% 41.2% 33.3%
Total Count 13 17 30
Expected Count 13.0 17.0 30.0
% within Kat. HDL 43.3% 56.7% 100.0%
% within BPH 100.0% 100.0% 100.0%

Chi-Square Te sts

As ymp. Sig. Ex act Sig. Ex act Sig.


Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 1.086b 1 .297
Continuity Correctiona .424 1 .515
Lik elihood Ratio 1.111 1 .292
Fis her's Ex act Test .440 .259
Linear-by-Linear
1.050 1 .306
As soc iation
N of Valid Cases 30
a. Computed only for a 2x 2 table
b. 1 c ells (25. 0%) have ex pect ed c ount less than 5. The minimum ex pec ted c ount is 4.
33.

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for Kat. HDL (Berisiko / Tidak Berisiko) 2.333 .466 11.693
For cohort BPH = Ya 1.667 .587 4.731
For cohort BPH = Tidak .714 .393 1.298
N of Valid Cases 30
Kat.Kadar Gula Puasa * BPH

Crosstab

BPH
Ya Tidak Total
Kat.Kadar Gula Berisik o Count 12 15 27
Puasa Ex pec ted Count 11.7 15.3 27.0
% within Kat.Kadar
44.4% 55.6% 100.0%
Gula Puas a
% within BPH 92.3% 88.2% 90.0%
Tidak Beris iko Count 1 2 3
Ex pec ted Count 1.3 1.7 3.0
% within Kat.Kadar
33.3% 66.7% 100.0%
Gula Puas a
% within BPH 7.7% 11.8% 10.0%
Total Count 13 17 30
Ex pec ted Count 13.0 17.0 30.0
% within Kat.Kadar
43.3% 56.7% 100.0%
Gula Puas a
% within BPH 100.0% 100.0% 100.0%

Chi-Square Te sts

As ymp. Sig. Ex act Sig. Ex act Sig.


Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square .136b 1 .713
Continuity Correctiona .000 1 1.000
Lik elihood Ratio .139 1 .709
Fis her's Ex act Test 1.000 .603
Linear-by-Linear
.131 1 .717
As soc iation
N of Valid Cases 30
a. Computed only for a 2x 2 table
b. 2 c ells (50. 0%) have ex pect ed c ount less than 5. The minimum ex pec ted c ount is 1.
30.

Ri sk Estim ate

95% Confidenc e
Int erval
Value Lower Upper
Odds Ratio for Kat.Kadar Gula Puasa
1.600 .129 19.838
(Berisiko / Tidak Beris iko)
For cohort BPH = Ya 1.333 .255 6.977
For cohort BPH = Tidak .833 .350 1.986
N of Valid Cas es 30
Sindrom Metabolik * BPH

Crosstab

BPH
Ya Tidak Total
Sindrom Metabolik Ya Count 9 8 17
Ex pec ted Count 7.4 9.6 17.0
% within Sindrom
52.9% 47.1% 100.0%
Metabolik
% within BPH 69.2% 47.1% 56.7%
Tidak Count 4 9 13
Ex pec ted Count 5.6 7.4 13.0
% within Sindrom
30.8% 69.2% 100.0%
Metabolik
% within BPH 30.8% 52.9% 43.3%
Total Count 13 17 30
Ex pec ted Count 13.0 17.0 30.0
% within Sindrom
43.3% 56.7% 100.0%
Metabolik
% within BPH 100.0% 100.0% 100.0%

Chi-Square Te sts

As ymp. Sig. Ex act Sig. Ex act Sig.


Value df (2-sided) (2-sided) (1-sided)
Pearson Chi-Square 1.475b 1 .225
Continuity Correctiona .710 1 .399
Lik elihood Ratio 1.497 1 .221
Fis her's Ex act Test .283 .200
Linear-by-Linear
1.426 1 .232
As soc iation
N of Valid Cases 30
a. Computed only for a 2x 2 table
b. 0 c ells (.0% ) have expected count less t han 5. The minimum expected count is 5.
63.

Risk Estimate

95% Confidence
Interval
Value Lower Upper
Odds Ratio for Sindrom Metabolik (Ya / Tidak) 2.531 .557 11.512
For cohort BPH = Ya 1.721 .679 4.363
For cohort BPH = Tidak .680 .365 1.265
N of Valid Cases 30